Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain

被引:16
作者
Dumont, Y
Moyse, E
Fournier, A
Quirion, R
机构
[1] McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr, Montreal, PQ H4H 1R3, Canada
[2] Univ Aix Marseille 3, INRA, CNRS, UMR,Lab Physiol Neurovegetat, F-13628 Aix En Provence, France
[3] Univ Quebec, Inst Natl Rech Sci, Inst Armand Frappier, Montreal, PQ, Canada
关键词
D O I
10.1124/jpet.105.089300
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Five distinct neuropeptide Y (NPY) receptors have been cloned thus far. Selective agonists and antagonists have recently been developed allowing for detailed functional studies as to the pathophysiological role of a given subtype as well as receptor binding characteristics and distribution. To precisely investigate the discrete localization and ligand selectivity profile of Y-4 and Y-5 receptors, a series of selective molecules were used as radioligands and competitors in rat brain tissues. Binding data revealed that Y-4 and Y-5 receptor-related agonists and antagonists competed with high affinity for specific I-125-[Leu(31), Pro(34)]human peptide YY (hPYY) binding in the presence of BIBO3304 [(R)-N-[[4-(aminocarbonylaminomethyl)-phenyl]methyl]-N-2-(diphenylacetyl)-argininamide trifluoroacetate] to mask Y-1 sites as well as specific I-125-labeled human pancreatic polypeptide (hPP) binding. Competition binding profiles were best fitted to a two-site model for both radioligands, suggesting the likely recognition of the Y-4 and Y-5 subtypes. We were surprised to find that the visualization of these specific binding sites by receptor autoradiography clearly revealed the distinct distribution of specific I-125-[Leu(31), Pro(34)]hPYY (in presence of Y-1 and Y-5 blockers) and I-125-hPP (in presence of Y-5 blocker) binding sites. Moreover, significant amounts of specific I-125-hPP binding were observed in the medial preoptic area, paraventricular nucleus of the hypothalamus, interpeduncular nucleus, and various brainstem nuclei, even after masking Y-4 and Y-5 receptors. Similar results were obtained using I-125-hPYY(3-36) in presence of Y-2 and Y-5 blockers. These results suggest the possible existence of at least one additional subtype of NPY receptor sites in the rat brain, with enrichment seen in midbrain and brainstem areas involved in the regulation of food intake and cardiorespiratory parameters.
引用
收藏
页码:99 / 108
页数:10
相关论文
共 40 条
[1]   Gut hormone PYY3-36 physiologically inhibits food intake [J].
Batterham, RL ;
Cowley, MA ;
Small, CJ ;
Herzog, H ;
Cohen, MA ;
Dakin, CL ;
Wren, AM ;
Brynes, AE ;
Low, MJ ;
Ghatei, MA ;
Cone, RD ;
Bloom, SR .
NATURE, 2002, 418 (6898) :650-654
[2]   Pancreatic polypeptide reduces appetite and food intake in humans [J].
Batterham, RL ;
Le Roux, CW ;
Cohen, MA ;
Park, AJ ;
Ellis, SM ;
Patterson, M ;
Frost, GS ;
Ghatei, MA ;
Bloom, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08) :3989-3992
[3]   Neuropeptide YY4 receptor homodimers dissociate upon agonist stimulation [J].
Berglund, MM ;
Schober, DA ;
Esterman, MA ;
Gehlert, DR .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (03) :1120-1126
[4]   Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes [J].
Berglund, MM ;
Hipskind, PA ;
Gehlert, DR .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 228 (03) :217-244
[5]   Characterization of N-(1-acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]-acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide YY2 receptor [J].
Bonaventure, P ;
Nepomuceno, D ;
Mazur, C ;
Lord, B ;
Rudolph, DA ;
Jablonowski, JA ;
Carruthers, NI ;
Lovenberg, TW .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (03) :1130-1137
[6]   Y-receptor affinity modulation by the design of pancreatic polypeptide/neuropeptide Y chimera led to Y5-receptor ligands with picomolar affinity [J].
Cabrele, C ;
Wieland, HA ;
Langer, M ;
Stidsen, CE ;
Beck-Sickinger, AG .
PEPTIDES, 2001, 22 (03) :365-378
[7]   Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor [J].
Criscione, L ;
Rigollier, P ;
Batzl-Hartmann, C ;
Rüeger, H ;
Stricker-Krongrad, A ;
Wyss, P ;
Brunner, L ;
Whitebread, S ;
Yamaguchi, Y ;
Gerald, C ;
Heurich, RO ;
Walker, MW ;
Chiesi, M ;
Schilling, W ;
Hofbauer, KG ;
Levens, N .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (12) :2136-2145
[8]  
DANIELS AJ, 1995, MOL PHARMACOL, V48, P425
[9]   Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells [J].
Dinger, MC ;
Bader, JE ;
Kóbor, AD ;
Kretzschmar, AK ;
Beck-Sickinger, AG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (12) :10562-10571
[10]   BIIE0246:: A selective and high affinity neuropeptide YY2 receptor antagonist [J].
Doods, H ;
Gaida, W ;
Wieland, HA ;
Dollinger, H ;
Schnorrenberg, G ;
Esser, F ;
Engel, W ;
Eberlein, W ;
Rudolf, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 384 (2-3) :R3-R5